Juan Abel Romero Loor
Allergy · Elmhurst, NYNPI 1275208183
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 142 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Sanofi at 32.4% of the total. 2025 is the largest year on record at $1,075, 2.3 times the $477 reported in 2021.
Across 142 payments — averaging $23.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$1K
- GSK$801
- Regeneron Healthcare Solutions, Inc.$480
- AstraZeneca$151
- Kaleo, Inc.$149
- Pfizer$118
- plus $555 from 14 others
What the payments were for
- Food & beverage$3,336100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 39 | $1,082 |
| GSK | 38 | $801 |
| Regeneron Healthcare Solutions, Inc. | 18 | $480 |
| AstraZeneca | 8 | $151 |
| Kaleo, Inc. | 8 | $149 |
| Pfizer | 5 | $118 |
| AbbVie | 4 | $81 |
| Genentech USA, Inc. | 3 | $74 |
| Novartis | 3 | $73 |
| Optinose US, Inc. | 3 | $67 |
| Amgen | 3 | $54 |
| Hikma Pharmaceuticals USA | 2 | $34 |
| ANI Pharmaceuticals, Inc. | 1 | $31 |
| Arcutis Biotherapeutics, Inc. | 1 | $24 |
| Merck | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Shield Therapeutics Inc | 1 | $22 |
| Boehringer Ingelheim | 1 | $20 |
| Viatris Specialty LLC | 1 | $16 |
| Vistapharm, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,336 in reported general payments places this provider in the 60th percentile of 92 allergy providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EucrisaCrisaborole | 13 | $10,731 |
| Spiriva RespimatTiotropium Bromide | 14 | $6,929 |
| Epinephrine | 20 | $4,980 |
| RyaltrisOlopatadine Hcl/Mometasone | 17 | $4,000 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 20 | $601 |
| Ammonium Lactate | 18 | $396 |
| Tamsulosin Hcl | 21 | $316 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $303 |
| Triamcinolone Acetonide | 14 | $296 |
| Azelastine Hcl | 18 | $224 |
| Montelukast Sodium | 31 | $182 |
| Famotidine | 13 | $114 |
| Fluticasone Propionate | 12 | $71 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEucrisa | $118 | $10,73113 claims |
| Hikma Pharmaceuticals USAEpinephrine, Ryaltris | $34 | $8,98037 claims |
| Boehringer IngelheimSpiriva Respimat | $20 | $6,92914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 92 allergy providers in New York.
Other allergy in Elmhurst
- Audrey WeissmanElmhurst$36K
- Vahid RahimianElmhurst$28K
- Marc BraunsteinHewlett$884K
- Allison RamseyRochester$643K
- Christopher SmithHorseheads$622K
- Anne MaitlandTarrytown$292K
- Yudhistira PersaudBronx$127K
- Michael KatlanAlbany$91K
- Michel AklJamestown$90K
- Juan SotomayorNorth Syracuse$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.